Posts in tag

TGA


Pete Evans’ company fined $25k for alleged COVID-19 advertising breaches, plus two companies and one WA woman fined over COVID-19 test kits The TGA has issued two infringement notices to …

Sildenafil, cannabidiol and ibuprofen among those to be considered for rescheduling  Australia’s medicine scheduling body is to consider another request to have sildenafil (Viagra) rescheduled. The June joint meeting of …

Regulators warn HCPs to stick to the facts on COVID-19 advertising and information  Health professionals are being warned to be careful with advertising and information they provide about COVID-19.  A …

First hand sanitiser ‘round table’ held in Australia looks at costs and availability, while TGA cuts legislative red tape on manufacturing to facilitate urgent and continued supply Last Friday, the …

Stakeholders have called on the general public to get their information about COVID-19 from reputable sources, as the TGA warns on inappropriate advertising The TGA says that it has identified …

Claims that rural pharmacies have been experiencing shortages after an “unprecedented run” on PBS medicines by large groups The Rural Pharmacy Network Australia (RPNA) has called for an investigation into …

No COVID-19 related medicine shortages yet, regulators say, but reports surface of rural supply issues The TGA is continuing to advise consumers against the stockpiling of medicines, saying that there …

The TGA has issued new advice telling Australians that there’s no need to stockpile medicines, as it could cause access problems for others On Tuesday, the Therapeutic Goods Administration said …

Massive increase in reports of medicine shortages following introduction of mandatory reporting The number of notifications of medicines shortages has jumped massively following the introduction of mandatory reporting in January …

Complaint filed to HCCC and TGA over therapeutic claims for IV therapy made by Australian clinics A number of Australian businesses are making therapeutic claims for IV therapy that a …

Patient frustration at difficulty accessing EpiPens is understandable – but it’s unfair to call pharmacy “complacent,” says a leading pharmacist Allergy and Anaphylaxis Australia chief executive Maria Said has told …

A labelling problem has seen Seqirus undertake a product defect correction over one batch of Palexia The TGA has advised consumers and health professionals that in consultation with the TGA, …